1. Unterschiede in der Nachweisbarkeit von Humanem Immunschwäche Virus Typ 1 in Tränenflüssigkeit und Blutlymphozyten
- Author
-
Bader L, V. Klauß, Lutz G. Gürtler, Ursula Kronawitter, O.-E. Lund, Johannes R. Bogner, Josef Eberle, Frank-Detlef Goebel, Arthur J. Mueller, and St. A. Geier
- Subjects
Isolation (health care) ,business.industry ,Lymphocyte ,virus diseases ,medicine.disease ,Virology ,Virus ,Ophthalmology ,Zidovudine ,medicine.anatomical_structure ,Acquired immunodeficiency syndrome (AIDS) ,Immunopathology ,Immunology ,medicine ,Tears ,Viral disease ,business ,medicine.drug - Abstract
Reported data on the isolation of the human immunodeficiency virus type 1 (HIV-1) from tears are controversial. The purpose of the study was to try to isolate HIV-1 from tears in a large sample of HIV-1-positive patients at different stages of infection. 53 tear samples were obtained from 50 patients. Additionally isolation of HIV-1 from peripheral blood lymphocytes (PBL) was attempted. HIV-1 was isolated from none (= 0%) of the 53 tear samples. Isolation from PBL was successful depending on absolute CD4+ lymphocyte count and Walter Reed staging (Walter Reed stage 6: 83%; stage 2 to 5: 11%; p less than 0.0001). Treatment with zidovudine was not related to the frequency of HIV-1 isolation. These results suggest that tears of patients infected with HIV-1 contain low or no quantities of tissue-culture-infectious units of HIV-1. Nosocomial infection with HIV-1 from tears appears to be unlikely. The known precautions for the prevention of spread of viral disease in ophthalmological practice are sufficient and should be strictly followed.
- Published
- 1992
- Full Text
- View/download PDF